Quotables
"I hate what they've done to my child...I would never let my own children watch it. "
Vladimir Zworykin, television pioneer ; Talking about an invention in which he played a critical role.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120128762 | Sphingomyelin Liposomes for the Treatment of Hyperactive Bladder Disorders The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to prevent, manage, ameliorate and/or treat disorders involving neuropathic pain an... | 05/24/2012 |
| 20120107300 | Cannabinoid Compositions and Methods Cannabinoid compositions and methods of administering said cannabinoid compositions are disclosed. The cannabinoid compositions disclosed herein include compounds which have been strategically selected to eliminate, or least mitigate, one of the negative side effects as... | 05/03/2012 |
| 20120070473 | Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions A method for inhibiting formation of adhesions following abdominal surgery which involves application of an anti-static fatty acid ethoxylated amide (Cocamide DEA) in a matrix that is placed in the peritoneal cavity at the conclusion of an abdominal surgery and which re... | 03/22/2012 |
| 20120040934 | OMEGA-3 ENRICHED FISH OIL-IN-WATER PARENTERAL NUTRITION EMULSIONS An emulsion is provided including: an oil component and a water component, the oil component including: fish oil triglycerides in an amount of about 60% to about 90% based on the weight of the oil component; wherein the fish oil triglycerides include omega-3 fatty acids... | 02/16/2012 |
| 20120039796 | Novel method for creating, suspending and stabilizing electronically modified oxygen derivatives, along with creating, suspending and stabilizing electronically modified reaction intermediates, in a bio compatible fluorocarbon suspension, for the purpose of inducing a cascading immune response in mammalian patients A bio compatible free radical suspension, comprising of oxygen and electronically modified reaction intermediates, where a fluorocarbon is used as an inert medium for stabilization of reaction intermediates. A stabilized bio compatible electronically modified derivative... | 02/16/2012 |
| 20120028921 | METHODS AND COMPOSITIONS USING OXIDIZED PHOSPHOLIPIDS The instant invention provides compositions, e.g., compositions comprising oxidized phospholipids, for the treatment of diseases, disorders and conditions, e.g., cute lung injury syndromes, sepsis, vascular leakage, edema, acute respiratory distress syndrome (ARDS) or a... | 02/02/2012 |
| 20120028922 | NATURAL MARINE SOURCE PHOSPHOLIPIDS COMPRISING POLYUNSATURATED FATTY ACIDS AND THEIR APPLICATIONS A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.... | 02/02/2012 |
| 20120014934 | Enhanced Natural Colors A natural color is concentrated to intensify color range and to provide useful amounts of one or more of anti-oxidant, nutritional, and anti-inflammatory compounds derived from one or more pigment sources. In a preferred embodiment, the pigment source is a fruit, a vege... | 01/19/2012 |
| 20120009239 | Prebiotic Formulations for use with Probiotics to Increase Probiotic Growth Rate and Activity Naturally occurring lecithins and/or oleic acid stimulate the growth and lactic acid producing activity of Lactobacillus and Bifidobacterium species of probiotic bacteria, and replace polysorbate 80 for those products. They can be used in naturally occurri... | 01/12/2012 |
| 20120009228 | Prebiotic Compositions for use with Probiotics to Increase Probiotic Growth Rate and Activity Naturally occurring lecithins and/or oleic acid stimulate the growth and lactic acid producing activity of Lactobacillus and Bifidobacterium species of probiotic bacteria, and replace polysorbate 80 for those products. They can be used in naturally occurri... | 01/12/2012 |
| 20110306577 | TOPICAL SKIN CREAM COMPRISING PHOSPHATIDYLCHOLINE DHA AND L-TYROSINE The present invention relates to compositions and methods of treating skin. In particular, the present invention relates to the topical application to the skin of compositions for the prevention and/or treatment of damage to skin.... | 12/15/2011 |
| 20110300236 | Method of treating impaired mitochondrial function Disclosed in certain embodiments is a pharmaceutical composition comprising a sugar; a Krebs cycle intermediate, precursor of a Krebs cycle intermediate, salt thereof, or combination thereof; and a component selected from the group consisting of an unsaturated lipid, ph... | 12/08/2011 |
| 20110294757 | POLAR LIPID MIXTURES, THEIR PREPARATION AND USES Disclosed herein are polar lipid mixtures, comprising glycerophospholipids such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS) and phosphatidyl-inositol (PI), and sphingolipids such as sphyngomyelin (SM). Most importantly, the ratio ... | 12/01/2011 |
| 20110286993 | USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY The present invention concerns a method for modulating the enzymatic activity of an enzyme, wherein said enzyme interacts with BMP, said method comprising the step of administering or inducing Hsp70, or a functional fragment or variant thereof, in a form suitable for al... | 11/24/2011 |
| 20110280918 | COMPOSITION COMPRISING PHOSPHOLIPIDS IN COMBINATION WITH ASCORBIC ACID AND COSMETIC PRODUCTS COMPRISING IT A paste composition comprising at least 25% phospholipids by weight in combination with at least 0.5% ascorbic acid by weight and a cosmetic product comprising this paste and a cosmetically acceptable carrier.... | 11/17/2011 |
| 20110280950 | SYNERGISTIC ANTIOXIDANT COMPOSITIONS Antioxidant compositions for the stabilization of fat sources against oxidation, stabilized fat source compositions, and methods of stabilizing fat sources against oxidation are described. In particular, an antioxidant emulsion that includes quercetin in addition to at ... | 11/17/2011 |
| 20110251158 | FULLERENE THERAPIES FOR INFLAMMATION AND INHIBITION OF BUILD-UP OF ARTERIAL PLAQUE Described herein are methods for treating inflammatory disorders or for inhibiting the build-up of arterial plaque. The methods comprise administering to a subject in need thereof a therapeutically effective amount of a synthetically modified fullerene.... | 10/13/2011 |
| 20110212922 | PROCESSES FOR THE PREPARATION OF PHOSPHATIDE SALTS The present invention discloses processes a process for the preparation of phosphatide-salt complexes, the process including the steps of: using at least one raw material lecithin as a substrate; and enzymatically processing at least one raw material lecithin with phosp... | 09/01/2011 |
| 20110177169 | OPHTHALMIC FORMULATIONS OF REVERSED LIQUID CRYSTALLINE PHASE MATERIALS AND METHODS OF USING The eye is effectively treated by providing it with formulations including uncoated cationically charged microparticles of reversed cubic phase or reversed hexagonal phase material. The treatment methods are effective; for a variety of diseases and conditions including ... | 07/21/2011 |
| 20110177158 | Liposomes Capable of Effectively Binding the Beta Amyloid Peptide Novel liposomes are described which are capable of effectively binding beta amyloid peptide and are useful for the treatment, prevention and diagnosis of Alzheimer's disease. Binding ability is provided by the presence in the formulation of particular natural lipids ide... | 07/21/2011 |
| 20110160161 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS The invention relates to concentrated therapeutic phospholipid compositions; methods for treating or preventing diseases associated with cardiovascular disease, metabolic syndrome, inflammation and diseases associated therewith, neurodevelopmental diseases, and neurodeg... | 06/30/2011 |
| 20110105433 | LECITHIN AND LC-PUFA The present invention relates generally to the prevention/and or stopping of the generation of off-flavours in food products. In particular is the present invention directed to the formulation of lipid raw material mixes and food products containing long chain polyunsat... | 05/05/2011 |
| 20110104279 | HEALING POWDER AND METHOD OF USE THEREOF A method for treating wounds, comprising providing a dry powder mixture, which when partially hydrated, forms a gel having an osmotic pressure sufficient to achieve and maintain antiseptic conditions in hydrated portions of the gel, the gelled portion comprising a bioco... | 05/05/2011 |
| 20110098249 | COMPOSITIONS AND METHODS OF TREATMENT FOR ALLEVIATING PREMENSTRUAL SYNDROME SYMPTOMS The present invention discloses pharmaceutical/nutritional compositions for alleviating symptoms associated with premenstrual syndrome (PMS) and methods of treatment for PMS using such pharmaceutical/nutritional composition including: at least 2% (w/w) phosphatidyl-L-se... | 04/28/2011 |
| 20110086110 | Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof The present invention provides analogs of benzoquinone-containing ansamycins and uses thereof for treating and modulating disorders associated with hyperproliferation, such as cancer. The present invention provides analogs of benzoquinone-containing ansamycins where the... | 04/14/2011 |
| 20110086091 | STABLE CRYSTAL MODIFICATIONS OF DOPC The invention relates to stable crystal modifications of (R,S)-, (R)- and (5S)-DOPC, to a process for the preparation of these modifications, and to the use thereof as constituent for the preparation of medicaments.... | 04/14/2011 |
| 20110052738 | TOPICAL PAIN FORMULATION A topical pain formulation, comprising one or more analgesic compounds and a plurality of skin penetrants.... | 03/03/2011 |
| 20110034415 | WALNUT EXTRACTS FOR NUTRACEUTICAL APPLICATIONS The invention describes to walnut oil extracts that have increased amounts of enriched in phospholipids, especially phosphatidylethanolamine (PE), phosphatidylcholine (PC), and phosphatidylinositol (PI) relative to walnut oil found in naturally occurring walnuts. It has... | 02/10/2011 |
| 20110028434 | LONG-CHAIN POLYUNSATURATED FATTY ACIDS (LC-PUFA) IN MATERNAL NUTRITION DURING PREGNANCY AND LACTATION The present invention relates in general to maternal food compositions. In particular, the present invention relates to maternal food compositions comprising LC-PUFA and their uses. Embodiments of the present invention relate to maternal food compositions comprising a s... | 02/03/2011 |
| 20110002896 | METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT Compositions and methods useful in the reduction of localized fat deposits in patients in need thereof using pharmacologically active detergents are disclosed. The pharmacologically active detergent compositions can additionally include anti-inflammatory agents, analges... | 01/06/2011 |
| 20100323030 | Composition with Anti-Inflammatory, Protein Synthesizing, Enzyme Deficiency Activating Genetic Therapy and Anti-Cancer Activity and Methods of Use A composition for treating damaged tissue and promoting healthy tissue growth, healing and tissue regeneration, wherein said composition comprises an extracellular matrix compound, a surface-active lipid, one or more enantioinerically pure L-amino acids or glycine, a hy... | 12/23/2010 |
| 20100317622 | Producing Method of Phospholipids Including Long-Chain Polyunsaturated Fatty Acids as Constituents, and Use of Such Phospholipids The present invention provides a method of efficiently and stably producing LCPUFA-PL. Specifically, the invention provides a method for producing phospholipids that contain LCPUFA as a constituent (LCPUFA-PL), wherein lipid producing cells producing lipids that contain... | 12/16/2010 |
| 20100316680 | ANTI-INFLAMMATORY PROPERTIES OF MARINE LIPID COMPOSITIONS Novel marine lipid compositions comprising triglycerides and omega-3 rich phospholipids are described. The compositions are characterized by providing highly bioavailable omega-3, increased tissue incorporation of omega-3 and reduced concentration of pro-inflammatory cy... | 12/16/2010 |
| 20100292186 | Pharmaceutical Composition for Treatment or Prevention of Liver Cancer An object of the present invention is to provide an excellent liver cancer treatment agent or prevention agent. The present invention provides a pharmaceutical composition for treating or preventing liver cancer, comprising menatetrenone, which is one species of vitamin... | 11/18/2010 |
| 20100273741 | Apparatus and Methods for Adipose Tissue Detection The present invention finds application in the field of cosmetic medicine and particularly relates to an apparatus for adipose tissue detection which comprises a first electronic circuit for generating a beam of electromagnetic waves, radiating means for orienting the b... | 10/28/2010 |
| 20100261676 | Use of an Endogenous Ligand for Peroxisome Proliferator Activated Receptor Alpha to Treat Liver Disorders Compositions comprising the peroxisome proliferator-activated receptor alpha (PPARα)-ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC) are disclosed. These compositions may be used for the prophylaxis and treatment of PPARα-related liver disorde... | 10/14/2010 |
| 20100247688 | PIRENZEPINE AND DERIVATIVES THEREOF AS ANTI-AMYLOID AGENTS The present invention relates to a compound that is capable of inhibiting the formation of β-amyloid plaques, of reducing and/or retarding the increase the β-amyloid plaque load in the brain of an animal, particularly a mammal, but especially a human. In particular, t... | 09/30/2010 |
| 20100239521 | METHOD FOR THE PREPARATION OF MICRO- AND NANO-SIZED CARRIER SYSTEMS FOR THE ENCAPSULATION OF BIOACTIVE SUBSTANCES The various embodiments herein provide a method for producing a carrier system for the encapsulation or entrapment of a bioactive agent. According to one embodiment herein, producing a carrier complex of a bioactive ingredient disposed within a carrier material, the met... | 09/23/2010 |
| 20100226977 | LOW VISCOSITY PHOSPHOLIPID COMPOSITIONS The invention relates to processing crustaceans such as krill to oils comprising phospholipids that are Newtonian fluids and/or and have low viscosity, and in particular to the production of oils containing astaxanthin and phospholipids that show Newtonian fluidity and ... | 09/09/2010 |
| 20100209364 | Emulsified Composition An emulsified composition comprises (A) petrolatum, (B) lecithin, (C) glycerin, (D) water and (E) a water-soluble polymer, wherein the content of the petrolatum (A) is 10 to 30 wt % relative to 100 wt % of the emulsified composition, and an internal phase of the emulsif... | 08/19/2010 |
